Primary Site >> Esophagus Cancer
Gene >> MDM2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. PMID: 8280379 |
Ref: [Prognostic factors for esophageal cancer--from the viewpoint of molecular biology]. PMID: 8687232 Ref: No evidence for the amplifications of MDM2 and C-myc genes involved in the genetic susceptibility to esophageal cancer in a high-risk area of north China. PMID: 8697432 |
Ref: Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. PMID: 9296509 Ref: Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. PMID: 9321930 |
Ref: The MDM2 gene amplification database. PMID: 9671804 Ref: [Prognostic factors of esophageal cancer]. PMID: 9838901 |
Ref: Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. PMID: 10914734 |
Ref: Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status. PMID: 11692147 |
Ref: Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. PMID: 11850840 Ref: Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1. PMID: 11870884 Ref: Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells. PMID: 12162819 Ref: Molecular and genetic characterization of a non-metastatic human esophageal cancer cell line, T.Tn expressing non-functional mutated p53. PMID: 12168098 Ref: MDM2 and CDK4 expression in carcinosarcoma of the esophagus: comparison with squamous cell carcinoma and review of the literature. PMID: 12565795 |
Ref: Cell culture in esophageal squamous cell carcinoma and the association with molecular markers. PMID: 12538476 |
Ref: Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. PMID: 15693850 |
Ref: Id-1 promotes proliferation of p53-deficient esophageal cancer cells. PMID: 16506209 Ref: Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. PMID: 16734736 Ref: Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. PMID: 17080019 |
Ref: PACT is a negative regulator of p53 and essential for cell growth and embryonic development. PMID: 17470788 |
Ref: Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. PMID: 19124015 Ref: p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. PMID: 19383811 |
Ref: p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. PMID: 20388212 |
Ref: Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus. PMID: 20922573 Ref: MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus. PMID: 21080085 |
Ref: Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility. PMID: 24844868 Ref: A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. PMID: 25214541 Ref: The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells. PMID: 26103161 Ref: MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis. PMID: 26550276 |
Ref: Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis. PMID: 25873358 Ref: Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study. PMID: 26054330 Ref: MDM2 gene amplification in esophageal carcinoma. PMID: 26796597 Ref: The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer. PMID: 27778235 |
Ref: Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors. PMID: 28258440 Ref: Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53. PMID: 28341911 Ref: Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer. PMID: 29163710 |
Ref: Survivin is critically involved in VEGFR2 signaling-mediated esophageal cancer cell survival. PMID: 30086460 |